Guangzhou Innogen Pharmaceutical Group Co., a Chinese biotech firm looking to tap the vast domestic market for obesity drugs, surged as much as 296% in its trading debut in Hong Kong.
www.bloomberg.com
#Chinese #Drugmaker #Aiming #Sell #Obesity #Meds #Soars #Debut
Chinese Drugmaker Aiming to Sell Obesity Meds Soars in HK Debut
